Media
Everything we have published, in one place
Announcements, letters to the people who fund and buy from us, the team's writing on how health markets get built, and the reading that shaped it.
Axmed named 2nd most innovative company in healthcare by Fast Company
Axmed is ranked second in healthcare globally in Fast Company's Most Innovative Companies of 2026, for its technology-first approach to procurement.
From Fast Company
Axmed secures $6M grant funding to scale the global infrastructure for access to healthcare products
Non-dilutive grant funding from the Gates Foundation to expand the marketplace, headquartered in Switzerland with regional headquarters in Nairobi.
Axmed

Axmed and LifeNet International partner to expand access to essential maternal and newborn health products
Axmed and LifeNet International equip frontline clinics with calibrated drapes, heat-stable carbetocin and training against postpartum haemorrhage.
Axmed
From Investor relations
Investor relations
What we publish for the people who fund, supply and buy from us: the yearly letter, the impact report and the numbers behind both.
2025
ReportAxmed Impact Report 2025
Patients reached, savings delivered and health products shipped in 2025, with the methodology behind every figure and an account of what did not work.
· Axmed · PDF, 15 MB
2025
LetterAxmed Stakeholder Letter 2025
Our progress in 2025, and the trade-offs that come with doing hard things at scale. Written for the people who fund, supply and buy from Axmed.
· Emmanuel Akpakwu
- PDF
Why the new normal in global health requires a new access model
Development financing has changed permanently. Axmed Global Health Advisory's Access360 framework builds access strategy into product development.
Axmed Global Health Advisory

How we are making pharmaceutical quality scalable and accessible with AI
How Axmed turns day-long manual prequalification and GMP and GDP audit work into real-time quality intelligence with AI. By Sofia Radley-Searle, COO.
Sofia Radley-Searle

The certificate was valid. The medicine was not.
Rethinking medicine quality in East Africa's supply chain: the medicine reached the patient, the label was correct, and it did not work.
Dr Onyango Michael